Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1

Simple item page
dc.contributor.authorVan Leth, Frank
dc.contributor.authorPhanuphak, Prahpan
dc.contributor.authorStroes, Erik
dc.contributor.authorGazzard, Brian
dc.contributor.authorCahn, Pedro
dc.contributor.authorRaffi, François
dc.contributor.authorWood, Robin
dc.contributor.authorBloch, Mark
dc.contributor.authorKatlama, Christine
dc.contributor.authorKastelein, John J P
dc.contributor.authorSchechter, Mauro
dc.contributor.authorMurphy, Robert L
dc.contributor.authorHorban, Andrzej
dc.contributor.authorHall, David B
dc.contributor.authorLange, Joep M A
dc.contributor.authorReiss, Peter
dc.date.accessioned2017-12-15T10:03:51Z
dc.date.available2017-12-15T10:03:51Z
dc.date.issued2004
dc.date.updated2017-11-03T13:40:27Z
dc.description.abstractPatients infected with HIV-1 initiating antiretroviral therapy (ART) containing a non-nucleoside reverse transcriptase inhibitor (NNRTI) show presumably fewer atherogenic lipid changes than those initiating most ARTs containing a protease inhibitor. We analyzed whether lipid changes differed between the two most commonly used NNRTIs, nevirapine (NVP) and efavirenz (EFV).
dc.identifierhttp://dx.doi.org/https://doi.org/10.1371/journal.pmed.0010019
dc.identifier.apacitationVan Leth, F., Phanuphak, P., Stroes, E., Gazzard, B., Cahn, P., Raffi, F., ... Reiss, P. (2004). Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1. <i>PLOS Medicine</i>, http://hdl.handle.net/11427/26733en_ZA
dc.identifier.chicagocitationVan Leth, Frank, Prahpan Phanuphak, Erik Stroes, Brian Gazzard, Pedro Cahn, François Raffi, Robin Wood, et al "Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1." <i>PLOS Medicine</i> (2004) http://hdl.handle.net/11427/26733en_ZA
dc.identifier.citationVan Leth, F., Phanuphak, P., Stroes, E., Gazzard, B., Cahn, P., Raffi, F., ... & Schechter, M. (2004). Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1. PLoS medicine, 1(1), e19.
dc.identifier.ris TY - Journal Article AU - Van Leth, Frank AU - Phanuphak, Prahpan AU - Stroes, Erik AU - Gazzard, Brian AU - Cahn, Pedro AU - Raffi, François AU - Wood, Robin AU - Bloch, Mark AU - Katlama, Christine AU - Kastelein, John J P AU - Schechter, Mauro AU - Murphy, Robert L AU - Horban, Andrzej AU - Hall, David B AU - Lange, Joep M A AU - Reiss, Peter AB - Patients infected with HIV-1 initiating antiretroviral therapy (ART) containing a non-nucleoside reverse transcriptase inhibitor (NNRTI) show presumably fewer atherogenic lipid changes than those initiating most ARTs containing a protease inhibitor. We analyzed whether lipid changes differed between the two most commonly used NNRTIs, nevirapine (NVP) and efavirenz (EFV). DA - 2004 DB - OpenUCT DP - University of Cape Town J1 - PLOS Medicine LK - https://open.uct.ac.za PB - University of Cape Town PY - 2004 T1 - Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1 TI - Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1 UR - http://hdl.handle.net/11427/26733 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/26733
dc.identifier.vancouvercitationVan Leth F, Phanuphak P, Stroes E, Gazzard B, Cahn P, Raffi F, et al. Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1. PLOS Medicine. 2004; http://hdl.handle.net/11427/26733.en_ZA
dc.language.isoeng
dc.publisher.departmentDivision of Infectious Disease and HIV Meden_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.sourcePLOS Medicine
dc.source.urihttp://journals.plos.org/plosmedicine/
dc.titleNevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1
dc.typeJournal Article
uct.type.filetypeText
uct.type.filetypeImage
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Van_Leth_Nevirapineefavirenz_2004.pdf
Size:
142.49 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Journal Articles